Intracerebral hemorrhage treatment

• Impact of transcranial direct current stimulation combined with median nerve stimulation on CRS-R in patients with prolonged disorders of consciousness after cerebral hemorrhage: protocol for a randomized controlled trial
• Role of Magnetic Resonance Venography in the Evaluation of Cerebral Veins and Sinuses Occlusion
• Effect of acupuncture on intracerebral mitochondrial function in mice with cerebral hemorrhage
• Anesthetic and perioperative management of pregnant patients undergoing neurosurgery: a case series from a single center in Morocco (2017-2024)
• Moyamoya disease in a 10-year-old male patient in the Middle East with the outcome of the surgery: A case report and literature review
• Sympathetic nerve block as an add-on therapy for intervention and prevention of cerebral vasospasm after subarachnoid hemorrhage
• Integrating clinical predictors and glial fibrillary acidic protein in prediction models for the prehospital identification of intracerebral haemorrhage in suspected stroke
• Parent Artery Occlusion Using Multiple Short iED Coils and n-Butyl Cyanoacrylate via a Marathon Microcatheter for a Dissecting Aneurysm of the Distal Posterior Inferior Cerebellar Artery With Severe Flexion of the Caudal Loop: A Case Report

GCS, systolic blood pressure, intraventricular hemorrhage, bleeding volume, and past blood pressure control are the main factors affecting the critical care needs of patients with ICH. ¹⁾.

Based on the MIMIC-III database, Yi et al. firstly described the dissimilarities in survival probability, mortality, and neurological recovery among mainstream treatments for intracerebral hemorrhage; secondly, patient classification was determined by important clinical features; and outcome variations among treatment groups were compared. The 28-day, 90-day, and in-hospital mortality in the craniotomy group were significantly lower than minimally invasive surgery (MIS) and non-surgical group patients; and, the medium/long-term mortality in the MIS group was significantly lower than the non-surgical group. The craniotomy group positively correlated with short-term GCS recovery compared with the MIS group; no difference existed between the non-surgical and MIS groups. The craniotomy group's 90-day survival probability and short-term GCS recovery were superior to the other two treatments in the subgroups of first GCS 3-12; this tendency also presented in the MIS group over the non-surgical group. For milder patients (first GCS > 12), the three treatment regimens had a minimal effect on patient survival, but the non-surgical group showed an advantage in short-term GCS recovery. Craniotomy patients have lower mortality and a better short-term neurological recovery in an ICH population, especially in short-to-medium term mortality and short-term neurological recovery over MIS patients. In addition, surgical treatment is recommendable for patients with a GCS ≤ 12. ²⁾.

Anticoagulation reversal, intensive blood pressure lowering, neurosurgery and access to critical care might all be beneficial in acute intracerebral hemorrhage (ICH) ³⁾.

see Spontaneous intracerebral hemorrhage treatment.

see Traumatic intracerebral hemorrhage treatment.